Skip to main content
. 2022 Jun 11;14(12):2885. doi: 10.3390/cancers14122885

Figure 6.

Figure 6

Biomarkers used in the OVA1® and Overa® assays developed by Aspira Women’s Health Inc. (A) The OVA1® assay incorporates TVU findings and menopausal status with changes in serum proteins ApoA-1, B2M, CA125, Transthyretin (Prealbumin) and Transferrin. (B) The Overa® assay is the second-generation model which incorporates two new serum biomarkers HE4 and FSH, along with three of the original biomarkers defined in the OVA1® assay. Image was recreated with permission from Aspira Women’s Health [176].